Biogen (BIIB)

Investing Cash Flow

-$5.32B

TTM · Period ending: · USD

BIIB logo

BIIB Investing Cash Flow

Latest reported-$5.32B
BIIB TTM Cash from Investing (-$29.50M → -$5.32B)
High-resolution chart · PNG

BIIB investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-295,265,000
-308,722,000
-104,997,000
-91,376,000
-59,301,000
-78,017,000
-210,080,000
-248,680,000
-218,180,000
-166,680,000
-158,680,000
-111,303,000
-142,303,000
-179,903,000
-155,203,000
-181,651,000
-129,851,000
-75,651,000
-82,051,000
-56,513,000
-63,613,000
-95,713,000
-92,313,000
-54,295,000
-25,995,000
-25,395,000
-70,295,000
-77,300,000
-102,000,000
-68,100,000
-66,700,000
-79,500,000
-41,800,000
-57,000,000
-23,900,000
-51,400,000
-61,500,000
-74,000,000
-48,300,000
-200,000
-21,000,000
-10,700,000
-29,500,000
-23,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.